MLICM
HRT

Metropolitan Life Insurance Company (MetLife)’s HireRight Holdings Corporation HRT Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio HRT Stock Details HRT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-768
Closed -$11K – 2273
2024
Q1 		$11K Sell
768
-541
-41% -$7.25K ﹤0.01% 2102
2023
Q4 		$17.6K Hold
1,309
– – ﹤0.01% 1972
2023
Q3 		$12.4K Hold
1,309
– – ﹤0.01% 2123
2023
Q2 		$14.8K Hold
1,309
– – ﹤0.01% 2091
2023
Q1 		$13.9K Sell
1,309
-544
-29% -$6.12K ﹤0.01% 2042
2022
Q4 		$22K Hold
1,853
– – ﹤0.01% 1966
2022
Q3 		$28.3K Hold
1,853
– – ﹤0.01% 1826
2022
Q2 		$26.3K Hold
1,853
– – ﹤0.01% 1905
2022
Q1 		$31.7K Sell
1,853
-5,503
-75% -$74.1K ﹤0.01% 1854
2021
Q4 		$118K Buy
+7,356
New +$123K ﹤0.01% 2376

Other funds holding HRT

AB
Amalgamated Bank New York $14.5B AUM 44.3% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s HRT Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of HireRight Holdings Corporation (HRT) in Q2 2024, closing a stake of 768 shares — an estimated $11K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in HRT in Q4 2021 and held it in 10 quarters. The position peaked at $118K in Q4 2021. 1 fund tracked by Wall St. Rank holds HRT as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining HireRight Holdings Corporation position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 768 HireRight Holdings Corporation shares in Q2 2024, an estimated $11K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in HireRight Holdings Corporation in Q4 2021 and held it in 10 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s HireRight Holdings Corporation position peaked at $118K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held HireRight Holdings Corporation as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.